Dr. Ping Chen (Chairman / CEO)

Bachelor of Science from Peking University

PhD from Duke University

Post doctoral researcher for two years with Professor Stephen Henesian, a famous scientist of Carbohydrate Chemistry at University of Montreal

Dr. Chen has been worked in BMS for 17 years as Senior Principal Scientist/Project Leader . As one of the main inventors, he participated in the research and development of Dasatinib, for the treatment of chronic leukemia. As a key scientist, he also participated in the research and development of several other drug candidates, including anti-virus, immunology and oncology drugs etc. He has published nearly 40 scientific papers and more than 40 patents . 

Mr. Shengli  Jiang ( Deputy General Manager)

Bachlor of Science from Applied Chemistry Department of Sichuan University (formerly Chengdu University of Science and Technology)

EMBA from China Europe International Business School (CEIBS)

Rich experience in process R & D and production scale-up with 8 invention patents.

He has ever held various technical and management positions in a few pharmaceutical companies, including engineer, chief engineer, general manager etc.

Dr. Zhenwei Cai (Senior VP of Chemistry)

Bachelor of Science from Nanjing University of Technology (formerly Nanjing Institute of Technology)

Master from East China University of Science and Technology

PhD from Rutgers University

Before join PharmaResources, Dr. Cai has been worked in BMS for 16 years as Senior Research Investigator Ⅱ. He is one of the main inventors of Brivanib. He has more than 30 published scientific papers and 21 patents, of which us7125875 was awarded the Thomas Edison patent invention award by the R&D Council of New Jersey in 2011.